Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$40.4 - $59.1 $653,470 - $955,942
16,175 New
16,175 $657,000
Q4 2022

Feb 13, 2023

BUY
$33.53 - $54.79 $373,222 - $609,867
11,131 New
11,131 $424,000
Q2 2022

Aug 15, 2022

SELL
$25.6 - $45.23 $129,945 - $229,587
-5,076 Reduced 42.58%
6,845 $274,000
Q1 2022

May 16, 2022

BUY
$33.33 - $44.6 $397,326 - $531,676
11,921 New
11,921 $445,000

Others Institutions Holding PTCT

About PTC THERAPEUTICS, INC.


  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $3.31B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Center Book Partners LP Portfolio

Follow Center Book Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Center Book Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Center Book Partners LP with notifications on news.